EI
Eldon C. Mayer III
Ex VP & Chief Commerc. Officer

Eldon C. Mayer III insider trades: Eiger BioPharmaceuticals (EIGR) stock buys and sales

Ex VP & Chief Commerc. Officer, Eiger BioPharmaceuticals Last trade Mar 17, 2023 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2018
2
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Eldon reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 17, 2023EIGR↓ Sell$5K
Mar 14, 2022EIGR↓ Sell$9K
Jan 7, 2022EIGR↓ Sell$8K
Jan 8, 2021EIGR↓ Sell$20K
Jan 24, 2020EIGR↑ Buy$68K
Nov 29, 2018EIGR↑ Buy$41K
Nov 27, 2018EIGR↑ Buy$208K
Sep 11, 2018RIGL↑ Buy$326K
Aug 23, 2018RIGL↑ Buy$282K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Eldon C. Mayer III's insider trades

Eldon C. Mayer III is Ex VP & Chief Commerc. Officer at Eiger BioPharmaceuticals (EIGR). Since Aug 23, 2018, Eldon has reported 5 open-market purchases worth $924K and 4 sales worth $41K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (16 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIGR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.